July 21, 2020
Today, the Oversight and Investigations Subcommittee of Energy and Commerce invited top officials from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer to testify on the development of a COVID-19 vaccine.
The University of Oxford and AstraZeneca reported positive data regarding the efficacy of their vaccine candidate emerging from a 1,000-person clinical trial.
The Food and Drug Administration (FDA) reissued an Emergency Use Authorization to Quest Diagnostics for its COVID-19 diagnostic test, which is the first of its kind using pooled samples.
- The FDA published a summary explaining its efforts to protect patients and consumers from COVID-19 fraud.
- To date, the FDA has issued 186 Emergency Use Authorizations for COVID-19 tests, including 153 molecular tests, 29 antibody tests, and 2 antigen tests.
National Institutes of Health Director Dr. Francis Collins spoke with NBC about the current surge of COVID-19 cases and the importance of accelerating vaccine and diagnostic development.
The Department of Health and Human Services launched a Coronavirus Data Hub, replacing the National Health Safety Network, for hospitals to report COVID-19 data to the federal government.
Until next time, this is your doctor's note.
Congressman Michael C. Burgess, M.D